Buoyed by Insiders, Flagship’s Evelo Hits Midpoint of IPO Range May 26, 2018 Evelo Biosciences, a biotech company based on technology licensed through the Polsky Center from UChicago Medicine’s Thomas Gajewski, debuted on Nasdaq. Read the full article >>
